To test the hypothesis that IDO1-expressing myeloma cells sustain the amplification of Treg cells, allogeneic naïve CD4+ T cells were challenged in vitro with myeloma cells in a MTLC. The gene discussed is CD4; the disease is plasma cell myeloma.